Henley Business Angels comprises members who invest in early stage companies and collaborate with other syndicates.
The funding round was backed by Henley Business Angels and Innovate UK.
"continued support will ensure that the impact of our newest technologies will not just be limited to sportsmen and women, but will benefit the broader population through medical applications of our technology as well"
The funding will support the clinical progression and regulatory advancement of the company proprietary nanoclay platform.
"advancing the development of [their] orthobiologics product, RENOVITE® nanoclay, and progressing through regulatory milestones to get this technology closer to clinic and spinal fusion patients."
Members of Henley Business Angels backed the soil-less farming innovator.
"We are excited to have the support of HBA and delighted that they appreciate the disruptive nature of our technology in helping to feed the world sustainably."
A syndicate of 14 Henley Business Angels members led a £1m funding round for the clean-in-place technology provider.
"Our team looks forward to getting down to the business of growth from here on in, and we see having the HBA investor group on side as a valuable source of experience and strength."
The cyber-security business secured the investment to support its sales strategy and reach new markets.
"This is a great addition to our funding round and we are very grateful for the help and guidance provided by Henley Business Angels. We are looking forward to updating the members with the progress made."
